Senior Clinical Research Associate – Hybrid (Australia)

Professional; Canberra; Hybrid; AUD 79,000 - 96,000; Full time

Benefits offered by this job

Health insurance

Retirement planning

Employee assistance program

Job summary

ICON Strategic Solutions in Australia seeks a Senior Clinical Research Associate (CRA) to monitor clinical trial sites and ensure GCP compliance. You will lead monitoring activities, support trial execution, and collaborate with cross-functional teams to maintain data integrity.

The role requires a strong independent work ethic, a bachelor's degree in a life sciences field, and extensive CRA experience. Hybrid work model in Australia and up to 60% travel are expected.

Qualifications

• Strong background in monitoring Clinical Trials and independent work.
• Familiarity with study protocols and regulatory requirements (GCP).
• Excellent communication and organizational skills.

Responsibilities

• Lead on trial monitoring tasks with a focus on quality and continuous improvement.
• Monitor sites to ensure adherence to protocols, regulatory requirements and GCP.
• Conduct site visits to assess performance, resolve issues and support trial execution.
• Collaborate with cross-functional teams for timely data collection and reporting.
• Provide training and guidance to site staff and other CRAs.
• Build and maintain relationships with site personnel and stakeholders.

Skills

Clinical trial monitoring

GCP knowledge

Site management

Regulatory compliance

Study coordination

Education

Bachelor's degree in life sciences

Tools

Clinical trial software

Job description

ICON Strategic Solutions in Australia seeks a Senior Clinical Research Associate (CRA) to monitor clinical trial sites and ensure GCP compliance. You will lead monitoring activities, support trial execution, and collaborate with cross-functional teams to maintain data integrity.

The role requires a strong independent work ethic, a bachelor's degree in a life sciences field, and extensive CRA experience. Hybrid work model in Australia and up to 60% travel are expected.